Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8

被引:168
作者
Bartz, SR
Emerman, M
机构
[1] Fred Hutchinson Canc Res Ctr, Div Mol Med, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA
关键词
D O I
10.1128/JVI.73.3.1956-1963.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Apoptosis contributes to the loss of CD4 cells during human immunodeficiency virus type 1 (HIV-1) infection. Although the product of the env gene, gp160/gp120, is known to play a role in cell death mediated by HIV-1, the role of other HIV-1 genes in the process is unclear. We found that HIV-1 lacking the env gene (HIV Delta env) still induced apoptosis in T-cell lines and primary CD4 T cells. The ability to induce apoptosis was attributable to Tat, a viral regulatory protein. Tat induction of apoptosis was separate from the transactivation function of Tat, required expression of the second exon of Tat, and was associated with the increased expression and activity of caspase-8 (casp-8), a signaling molecule in apoptotic pathways. Moreover, induction of apoptosis could be prevented by treating cells with an inhibitor of casp-8. In addition, we show that HIV-1 Delta env infection and Tat expression increased the sensitivity of cells to Fas-mediated apoptosis, an apoptotic pathway that signals via casp-8. The up-regulation of casp-8 by HIV-1 Tat expression may contribute to the increased apoptosis and sensitivity to apoptotic signals observed in the cells of HN-l-infected persons.
引用
收藏
页码:1956 / 1963
页数:8
相关论文
共 47 条
  • [1] Ameisen J C, 1995, Curr Top Microbiol Immunol, V200, P195
  • [2] PROGRAMMED CELL-DEATH AND AIDS - FROM HYPOTHESIS TO EXPERIMENT
    AMEISEN, JC
    [J]. IMMUNOLOGY TODAY, 1992, 13 (10): : 388 - 391
  • [3] HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B
    Ayyavoo, V
    Mahboubi, A
    Mahalingam, S
    Ramalingam, R
    Kudchodkar, S
    Williams, WV
    Green, DR
    Weiner, DB
    [J]. NATURE MEDICINE, 1997, 3 (10) : 1117 - 1123
  • [4] Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein
    Bartz, SR
    Vodicka, MA
    [J]. METHODS-A COMPANION TO METHODS IN ENZYMOLOGY, 1997, 12 (04): : 337 - 342
  • [5] Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G(2) accumulation by a mechanism which differs from DNA damage checkpoint control
    Bartz, SR
    Rogel, ME
    Emerman, M
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (04) : 2324 - 2331
  • [6] Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
    Boldin, MP
    Goncharov, TM
    Goltsev, YV
    Wallach, D
    [J]. CELL, 1996, 85 (06) : 803 - 815
  • [7] FADD, A NOVEL DEATH DOMAIN-CONTAINING PROTEIN, INTERACTS WITH THE DEATH DOMAIN OF FAS AND INITIATES APOPTOSIS
    CHINNAIYAN, AM
    OROURKE, K
    TEWARI, M
    DIXIT, VM
    [J]. CELL, 1995, 81 (04) : 505 - 512
  • [8] The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: Possible implications for the pathogenesis of AIDS
    Conti, L
    Rainaldi, G
    Matarrese, P
    Varano, B
    Rivabene, R
    Columba, S
    Sato, A
    Belardelli, E
    Malorni, W
    Gessani, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (03) : 403 - 413
  • [9] In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains
    FernandesAlnemri, T
    Armstrong, RC
    Krebs, J
    Srinivasula, SM
    Wang, L
    Bullrich, F
    Fritz, LC
    Trapani, JA
    Tomaselli, KJ
    Litwack, G
    Alnemri, ES
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) : 7464 - 7469
  • [10] GAYNOR RB, 1995, CURR TOP MICROBIOL, V193, P51